RECRUITINGINTERVENTIONAL

Decision Aid (DA) for Renal Patients

Evaluation of a Decision Aid in the Treatment Planning of Small Renal Tumors

About This Trial

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

Who May Be Eligible (Plain English)

Who May Qualify: - Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter. - Patients scheduled for standard-of-care clinical exams with the NYU Urology Department Who Should NOT Join This Trial: - Stage IV cancer of any type - Inability to provide willing to sign a consent form - Vulnerable subjects will not be recruited Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter. * Patients scheduled for standard-of-care clinical exams with the NYU Urology Department Exclusion Criteria: * Stage IV cancer of any type * Inability to provide informed consent * Vulnerable subjects will not be recruited

Treatments Being Tested

OTHER

Decision Aid (DA) Web Tool

The DA web tool provides information on kidney masses and available treatment options. It uses risk communication, directed teaching, and interactive benefit-harm assessment to present information.

OTHER

Institutional Pamphlet

The institutional pamphlet provides information on kidney masses, but does not use risk communication, directed teaching, or interactive benefit-harm assessment.

Locations (1)

NYU Langone Health

New York, New York, United States